BYSL p.Ile434Val
c.1300A>G · VCV3262347
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0518 | likely benign |
|---|---|---|
| REVEL | 0.026 | moderately benign-leaning |
| SaProt | LLR -4.60 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP -1.3 | GERP -4.4 |
| Regional constraint | o/e 0.90 | unconstrained · MANE · 11 kb · p 0.019 · regional, not allelic |
| Overall | ||
| CADD | 0.159 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| African / African-Americangrpmax | 0.105% | 949 |
| Remaining individualsnot grpmax-eligible | 0.00481% | 20,786 |
| Admixed American | 0.00167% | 59,908 |
| European (non-Finnish) | 8.49e-05% | 1,177,310 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- BYSL
- Protein
- p.Ile434Val
- Coding
- c.1300A>G
- MANE Select
- NM_004053
- Type
- single nucleotide variant
- Location
- chr6:41932692 (GRCh38)
- Gene constraint
- LOEUF 0.632 · pLI 0.07 (gnomAD)
- Structure
- AlphaFold pLDDT 78.24 · 13 PDB
Similar variants
- MED20 p.Arg26Trp Uncertain significance ★★ ⚠ same type
- MED20 p.Met30Val Uncertain significance ★★ ⚠ same type
- BYSL p.Ala279Pro Uncertain significance ★ ⚠ same type
- BYSL p.Ala28Glu Uncertain significance ★ ⚠ same type
- BYSL p.Ala71Gly Uncertain significance ★ ⚠ same type
- BYSL p.Arg131His Uncertain significance ★ ⚠ same type
- BYSL p.Arg145His Uncertain significance ★ ⚠ same type
- BYSL p.Arg189Gln Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/bysl-p-ile434val (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown